Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-Cell therapy, in patients with relapsed and refractory multiple myeloma: Updated KarMMa results

Autor: Einsele, H, Oriol, A, San-Miguel, J, Kansagra, A, Madduri, D, Shah, N, Moreau, P, Yakoub-Agha, I, Delforge, M, Cavo, M, Goldschmidt, H, Weisel, K, Rambaldi, A, Reece, D, Rodriguez-Otero, P, Petrocca, F, Connarn, JN, Patel, P, Huang, L, Campbell, TB, Hege, K, Munshi, NC

Publikováno v: Oncology Research and Treatment
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::0d930de9dfc79d55918e592bbe3f160d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1807

Anti-BCMA-CAR-T-Zell-Therapie bei einem Patienten mit rezidiviertem und refraktärem Multiplen Myelom nach einer COVID-19-Infektion: ein Fallbericht. (German)

Autor: Madduri, D., Parekh, S., Campbell, T.B., Neumann, F., Petrocca, F., Jagannath, S.

Publikováno v: Kompass Onkologie; 2022, Vol. 9 Issue 1, p40-45, 6p

Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.

Autor: Madduri, D., Parekh, S., Campbell, T. B., Neumann, F., Petrocca, F., Jagannath, S.

Publikováno v: Journal of Medical Case Reports; 2/19/2021, Vol. 15 Issue 1, p1-6, 6p

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007;26:7590-7595

Autor: Visone R., Pallante P., Vecchione A., Cirombella R., Ferraro A., Volinia S., Coluzzi S., Leone V., Borbone E., Liu C. G., Petrocca F., Troncone G., Calin G. A., Scarpa A., Colato C., Santoro M., Croce C. M., Fusco A., FERRACIN, MANUELA, TALLINI, GIOVANNI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::963b80570f03acc3007c6ecf06a27f3e
http://hdl.handle.net/11585/59496

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.